SAMD13 and bone cancer: As shown in Additional file 1: Figure S1, SAMD13 was upregulated in blood, brain, liver, and bone cancers, while downregulated in colon, breast, kidney, head and neck, tongue, thyroid, adrenal gland, pharynx, testis, and endometrial cancers.